Table 2.
Demographic and clinical characteristics of participants.
| EX (n = 13) | NC (n = 15) | Total (n = 28) | |
|---|---|---|---|
| Demographic | |||
| Age (years) | 66.5 ± 7.4 | 66.3 ± 6.7 | 66.4 ± 6.9 |
| Gender | |||
| Male | 11 | 10 | 21 |
| Female | 2 | 5 | 7 |
| Race (%) | |||
| Asian | 7 (53.9%) | 2 (13.3%) | 9 (32.1%) |
| Hispanic | 1 (7.7%) | 5 (33.3%) | 6 (21.4%) |
| Caucasian | 1 (7.7%) | 5 (33.3%) | 6 (21.4%) |
| Pacific Islander | 3 (23%) | 1 (6.7%) | 4 (14.3%) |
| African American | 1 (7.7%) | 2 (13.3%) | 3 (10.7%) |
| Anthropomorphic | |||
| BMI (kg/m2) | 28.5 ± 3.3 | 29.1 ± 4.6 | 28.8 ± 4.0 |
| Waist/Hip ratio | 1.0 ± 0.1 | 1.0 ± 0.1 | 1.0 ± 0.1 |
| Mid-Arm Circumference | 12.1 ± 1.7 | 11.6 ± 1.4 | 11.9 ± 1.6 |
| Adiposity | |||
| Skin Fold Thickness (inches) | |||
| Abdominal | 17.7 ± 7.3 | 18.8 ± 6.7 | 18.3 ± 6.9 |
| Suprailiac | 13.0 ± 8.1 | 12.6 ± 4.5 | 12.8 ± 6.3 |
| Tricep | 13.0 ± 5.4 | 14.5 ± 5.8 | 13.8 ± 5.5 |
| Medical History | |||
| Hypertension | 13 (100%) | 15 (100%) | 28 (100%) |
| Type II DM | 9 (69%) | 10 (66.7%) | 19 (67.9%) |
| CAD | 5 (38.5%) | 5 (33.3%) | 10 (35.7%) |
| Stroke | 3 (23%) | 3 (20%) | 6 (21.4%) |
| Liver Disease | 1(7.7%) | 3 (20%) | 4 (14.3%) |
| Cancer | 1(7.7%) | 3 (20%) | 4 (14.3%) |